306 related articles for article (PubMed ID: 21371143)
21. Alloimmunity to RhD in humans.
Urbaniak SJ
Transfus Clin Biol; 2006; 13(1-2):19-22. PubMed ID: 16574456
[TBL] [Abstract][Full Text] [Related]
22. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
[TBL] [Abstract][Full Text] [Related]
23. Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.
Illanes S; Soothill P
Prenat Diagn; 2010 Jul; 30(7):668-73. PubMed ID: 20572110
[TBL] [Abstract][Full Text] [Related]
24. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
25. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
Moncharmont P
Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
[TBL] [Abstract][Full Text] [Related]
26. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
[TBL] [Abstract][Full Text] [Related]
27. Red-cell and platelet alloimmunisation in pregnancy.
Egbor M; Knott P; Bhide A
Best Pract Res Clin Obstet Gynaecol; 2012 Feb; 26(1):119-32. PubMed ID: 22119066
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
[TBL] [Abstract][Full Text] [Related]
29. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
30. Feto - maternal haemorrhage in parturients: Incidence and its determinants.
Adeniji AO; Mabayoje VO; Raji AA; Muhibi MA; Tijani AA; Adeyemi AS
J Obstet Gynaecol; 2008 Jan; 28(1):60-3. PubMed ID: 18259901
[TBL] [Abstract][Full Text] [Related]
31. Haemolytic disease of the fetus and newborn.
de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
[TBL] [Abstract][Full Text] [Related]
32. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
[TBL] [Abstract][Full Text] [Related]
33. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
34. Estimation of the number of females at risk of isoimmunization to the Rho (D) antigen in a sample of the population attended at the Instituto Mexicano del Seguro Social.
Zavala C; Velázquez-Ferrari MA; Navarrete C; Rosales-Corona J; Lisker R
Arch Invest Med (Mex); 1983; 14(2):199-206. PubMed ID: 6416200
[No Abstract] [Full Text] [Related]
35. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
Hyland CA; O'Brien H; Flower RL; Gardener GJ
Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of Rhesus negativity among pregnant women in Enugu, Southeast Nigeria.
Okeke TC; Ocheni S; Nwagha UI; Ibegbulam OG
Niger J Clin Pract; 2012; 15(4):400-2. PubMed ID: 23238187
[TBL] [Abstract][Full Text] [Related]
37. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.
Wang QP; Dong GT; Wang XD; Gu J; Li Z; Sun AY; Shao CP; Pan ZL; Huang LH; Xie WX; Sun GM; Chen JJ; Pei H; Yang XJ; Shan PN
Blood Transfus; 2014 Apr; 12(2):238-43. PubMed ID: 23399369
[TBL] [Abstract][Full Text] [Related]
38. Secondary anti-D immunization by Del red blood cells.
Yasuda H; Ohto H; Sakuma S; Ishikawa Y
Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
[TBL] [Abstract][Full Text] [Related]
39. Red Blood Cell Alloimmunization in the Pregnant Patient.
Webb J; Delaney M
Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
[TBL] [Abstract][Full Text] [Related]
40. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
Vŭlcheva B; Spasova K
Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
